PacWest Financial Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$16.5M Buy
91,810
+2,430
+3% +$436K 0.97% 43
2016
Q3
$1.86M Buy
89,380
+8,310
+10% +$173K 1.14% 40
2016
Q2
$2.18M Sell
81,070
-760
-0.9% -$20.4K 1.36% 23
2016
Q1
$2.22M Sell
81,830
-1,234
-1% -$33.4K 1.43% 23
2015
Q4
$2.41M Sell
83,064
-3,530
-4% -$103K 1.61% 19
2015
Q3
$2.35M Sell
86,594
-410
-0.5% -$11.1K 1.74% 14
2015
Q2
$2.38M Buy
87,004
+200
+0.2% +$5.48K 1.68% 15
2015
Q1
$2.32M Buy
86,804
+2,100
+2% +$56.1K 1.64% 15
2014
Q4
$1.79M Buy
84,704
+1,900
+2% +$40.2K 1.27% 31
2014
Q3
$1.97M Sell
82,804
-3,030
-4% -$72.2K 1.47% 21
2014
Q2
$1.98M Sell
85,834
-416
-0.5% -$9.61K 1.47% 22
2014
Q1
$1.97M Buy
86,250
+1,350
+2% +$30.8K 1.53% 20
2013
Q4
$1.57K Sell
84,900
-4,770
-5% -$88 0.47% 33
2013
Q3
$1.52M Buy
89,670
+650
+0.7% +$11K 1.31% 31
2013
Q2
$1.38M Buy
+89,020
New +$1.38M 1.31% 31